FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000519574> ?p ?o ?g. }

• W2000519574 endingPage "1010" @default.
• W2000519574 startingPage "1001" @default.
• W2000519574 abstract "BACKGROUND. Letrozole is safe and effective in postmenopausal women with estrogen receptor-positive early breast cancer, but long-term aromatase inhibitor use may cause bone loss and increase fracture risk. This study evaluated an immediate or delayed strategy of bone protection therapy with zoledronic acid. METHODS. A total of 1065 patients who were receiving adjuvant letrozole were randomized to immediate-start or delayed-start zoledronic acid (4 mg intravenously biannually for 5 years). The delayed group received zoledronic acid if lumbar spine or total hip T-score decreased below −2.0 or when a nontraumatic fracture occurred. The primary endpoint was change in lumbar spine bone mineral density (BMD) at Month 12. Secondary endpoints included changes in total hip BMD, serum bone turnover markers, and safety at Month 12. RESULTS. Lumbar spine BMD increased from baseline in the immediate arm, while it decreased from baseline in delayed-arm patients. At Month 12, the differences between the groups in lumbar spine and total hip BMD were 5.7% (P < .0001; 95% confidence intervals [CI], 5.2% to 6.1%), and 3.6% (P < .0001; 95% CI, 3.3 to 4.0%), respectively. Both regimens were well tolerated with few serious adverse events. Bone pain was higher in the immediate group, as expected, because some patients experienced acute-phase reactions after zoledronic acid infusion. CONCLUSIONS. At 12 months, immediate zoledronic acid therapy prevented bone loss in postmenopausal women who were receiving adjuvant letrozole. Cancer 2008. © 2008 American Cancer Society." @default.
• W2000519574 created "2016-06-24" @default.
• W2000519574 creator A5007579054 @default.
• W2000519574 creator A5011410319 @default.
• W2000519574 creator A5011862433 @default.
• W2000519574 creator A5017495356 @default.
• W2000519574 creator A5022933672 @default.
• W2000519574 creator A5046752881 @default.
• W2000519574 creator A5051980635 @default.
• W2000519574 creator A5065438961 @default.
• W2000519574 creator A5071040536 @default.
• W2000519574 creator A5071658752 @default.
• W2000519574 creator A5080670134 @default.
• W2000519574 date "2008-01-01" @default.
• W2000519574 modified "2023-10-18" @default.
• W2000519574 title "Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole" @default.
• W2000519574 cites W1975344303 @default.
• W2000519574 cites W1976680910 @default.
• W2000519574 cites W1993035292 @default.
• W2000519574 cites W2036125852 @default.
• W2000519574 cites W2037970787 @default.
• W2000519574 cites W2096446019 @default.
• W2000519574 cites W2101881391 @default.
• W2000519574 cites W2102796588 @default.
• W2000519574 cites W2103314990 @default.
• W2000519574 cites W2107118598 @default.
• W2000519574 cites W2114344041 @default.
• W2000519574 cites W2116605720 @default.
• W2000519574 cites W2121099142 @default.
• W2000519574 cites W2139959697 @default.
• W2000519574 cites W2143151890 @default.
• W2000519574 cites W2160287478 @default.
• W2000519574 cites W2163688875 @default.
• W2000519574 cites W2165929198 @default.
• W2000519574 cites W4236203212 @default.
• W2000519574 doi "https://doi.org/10.1002/cncr.23259" @default.
• W2000519574 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18205185" @default.
• W2000519574 hasPublicationYear "2008" @default.
• W2000519574 type Work @default.
• W2000519574 sameAs 2000519574 @default.
• W2000519574 citedByCount "196" @default.
• W2000519574 countsByYear W20005195742012 @default.
• W2000519574 countsByYear W20005195742013 @default.
• W2000519574 countsByYear W20005195742014 @default.
• W2000519574 countsByYear W20005195742015 @default.
• W2000519574 countsByYear W20005195742016 @default.
• W2000519574 countsByYear W20005195742017 @default.
• W2000519574 countsByYear W20005195742018 @default.
• W2000519574 countsByYear W20005195742019 @default.
• W2000519574 countsByYear W20005195742020 @default.
• W2000519574 countsByYear W20005195742021 @default.
• W2000519574 countsByYear W20005195742022 @default.
• W2000519574 countsByYear W20005195742023 @default.
• W2000519574 crossrefType "journal-article" @default.
• W2000519574 hasAuthorship W2000519574A5007579054 @default.
• W2000519574 hasAuthorship W2000519574A5011410319 @default.
• W2000519574 hasAuthorship W2000519574A5011862433 @default.
• W2000519574 hasAuthorship W2000519574A5017495356 @default.
• W2000519574 hasAuthorship W2000519574A5022933672 @default.
• W2000519574 hasAuthorship W2000519574A5046752881 @default.
• W2000519574 hasAuthorship W2000519574A5051980635 @default.
• W2000519574 hasAuthorship W2000519574A5065438961 @default.
• W2000519574 hasAuthorship W2000519574A5071040536 @default.
• W2000519574 hasAuthorship W2000519574A5071658752 @default.
• W2000519574 hasAuthorship W2000519574A5080670134 @default.
• W2000519574 hasConcept C121608353 @default.
• W2000519574 hasConcept C126322002 @default.
• W2000519574 hasConcept C126894567 @default.
• W2000519574 hasConcept C141071460 @default.
• W2000519574 hasConcept C168563851 @default.
• W2000519574 hasConcept C203092338 @default.
• W2000519574 hasConcept C2776166826 @default.
• W2000519574 hasConcept C2776326535 @default.
• W2000519574 hasConcept C2776541429 @default.
• W2000519574 hasConcept C2776886416 @default.
• W2000519574 hasConcept C2778504769 @default.
• W2000519574 hasConcept C2778812593 @default.
• W2000519574 hasConcept C530470458 @default.
• W2000519574 hasConcept C71924100 @default.
• W2000519574 hasConceptScore W2000519574C121608353 @default.
• W2000519574 hasConceptScore W2000519574C126322002 @default.
• W2000519574 hasConceptScore W2000519574C126894567 @default.
• W2000519574 hasConceptScore W2000519574C141071460 @default.
• W2000519574 hasConceptScore W2000519574C168563851 @default.
• W2000519574 hasConceptScore W2000519574C203092338 @default.
• W2000519574 hasConceptScore W2000519574C2776166826 @default.
• W2000519574 hasConceptScore W2000519574C2776326535 @default.
• W2000519574 hasConceptScore W2000519574C2776541429 @default.
• W2000519574 hasConceptScore W2000519574C2776886416 @default.
• W2000519574 hasConceptScore W2000519574C2778504769 @default.
• W2000519574 hasConceptScore W2000519574C2778812593 @default.
• W2000519574 hasConceptScore W2000519574C530470458 @default.
• W2000519574 hasConceptScore W2000519574C71924100 @default.
• W2000519574 hasIssue "5" @default.
• W2000519574 hasLocation W20005195741 @default.
• W2000519574 hasLocation W20005195742 @default.
• W2000519574 hasOpenAccess W2000519574 @default.
• W2000519574 hasPrimaryLocation W20005195741 @default.

• next